Evidence map›Paper›PMID 33375213›Full record

ArticleInternational journal of environmental research and public health2020

Spatial and Temporal Analysis of Lung Cancer in Shenzhen, 2008-2018.

Lin Lei, Anyan Huang, Weicong Cai, Ling Liang, Yirong Wang, Fangjiang Liu, Ji Peng

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lin LeiDepartment of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen 518020, China.ORCID 0000-0001-6687-6898
Anyan HuangDepartment of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen 518020, China.
Weicong CaiDepartment of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen 518020, China.ORCID 0000-0002-1597-4313
Ling LiangDepartment of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen 518020, China.
Yirong WangDepartment of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen 518020, China.
Fangjiang LiuDepartment of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen 518020, China.
Ji PengDepartment of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen 518020, China.ORCID 0000-0002-4677-092X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is the most commonly diagnosed cancer in China. The incidence trend and geographical distribution of lung cancer in southern China have not been reported. The present study explored the temporal trend and spatial distribution of lung cancer incidence in Shenzhen from 2008 to 2018. The lung cancer incidence data were obtained from the registered population in the Shenzhen Cancer Registry System between 2008 and 2018. The standardized incidence rates of lung cancer were analyzed by using the joinpoint regression model. The Moran's I method was used for spatial autocorrelation analysis and to further draw a spatial cluster map in Shenzhen. From 2008 to 2018, the average crude incidence rate of lung cancer was 27.1 (1/100,000), with an annual percentage change of 2.7% (

Indexed as

Lung NeoplasmsChinaCluster AnalysisFemaleHumansIncidenceMaleRegistriesSpatio-Temporal Analysiscancer registryincidence ratelung cancerspatial autocorrelationtemporal trend

Identifiers

PMID33375213
PMCPMC7793115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.